Chemotherapy-Based Stem Cell Mobilization Does Not Result in Significant Paraprotein Reduction in Myeloma Patients in the Era of Novel Induction Regimens-Reference-Cited by-同舟云学术

Chemotherapy-Based Stem Cell Mobilization Does Not Result in Significant Paraprotein Reduction in Myeloma Patients in the Era of Novel Induction Regimens

Published:2018-02 Issue:2 Volume:24 Page:276-281
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Oyekunle Anthony^ORCID,Shumilov Evgenii,Kostrewa Philippe,Burchert Andreas,Trümper Lorenz,Wuchter Patrick,Wulf Gerald,Bacher Ulrike,Kröger Nicolaus

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference37 articles.

1. Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group;Ludwig;Blood,2008

2. Allogeneic stem cell transplantation in multiple myeloma: immunotherapy and new drugs;Festuccia;Expert Opin Biol Ther,2015

3. Treatment of relapsed and refractory multiple myeloma in the era of novel agents;van de Donk;Cancer Treat Rev,2011

4. New developments in conditioning regimens before auto-SCT in multiple myeloma;Moreau;Bone Marrow Transplant,2011

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing Autologous Stem Cell Transplantation in Multiple Myeloma: The Impact of Intensive Chemomobilization;Transplantation and Cellular Therapy;2024-08

2. Autologous peripheral blood stem cell harvest timing by absolute neutrophil count in children and young adult patients: Single-institute experience;Pediatrics & Neonatology;2024-08

3. Comparison of two autologous hematopoietic stem cell mobilization strategies in patients with multiple myeloma: CE plus G‐CSF versus G‐CSF only: A single‐center retrospective analysis;Transfusion;2024-04-10

4. Overview on novel strategies and current guidelines for hematopoietic stem cell mobilisation and collection;Transfusion and Apheresis Science;2023-12

5. Peripheral blood stem cell mobilisation following bortezomib, lenalidomide and dexamethasone induction for multiple myeloma: a real‐world single‐centre experience;Internal Medicine Journal;2023-07-23